Aspen to market last-resort Aids drug across Africa

Author: Samantha Enslin, Business Report [So. Africa], Published on: 5 April 2007

Aspen plans to market a salvage treatment, Prezista, for Aids patients in 20 sub-Saharan African countries through a deal with Ireland's Tibotec Pharmaceuticals [a division of Johnson & Johnson (J&J)]...The deal was structured so that Aspen would market Prezista...on a cost recovery basis...Tibotec…will not earn anything...Salvage treatment is a last resort for Aids patients…[Senior executive of Aspen] Nicolaou, said: "In Africa only about 20 percent to 25 percent of the 6 million Africans who require treatment are receiving it…"...

Read the full post here

Related companies: Aspen Pharmacare Johnson & Johnson Tibotec (part of Johnson & Johnson)